In Vitro Studies

 

Raptim Research Private Limited is a global independent and internationally accredited Contract Research Organization (CRO), established in 2005 with state-of-the-art clinical research facilities at Mumbai and Gandhinagar.

Raptim provides different types of In-vitro services
to demonstrate Bioequivalence.

    Contact us for more details

    Name*

    Company Name*

    E-Mail*

    Phone

    Comments

    Raptim's Experience

    1. In Vitro Release Test (IVRT) and In Vitro Permeation Test (IVPT) for topical products

    IVRT Studies

    • Acyclovir Ointment
    • Diclofenac Gel
    • Lidocaine Gel
    • Nystatin & Triamcinolone Ointment
    • Nystatin Cream
    • Nystatin Ointment
    • Dapsone Gel 5% & 7.5%

    IVPT Studies

    • Acyclovir Cream
    • Doxepin Cream
    • Diclofenac Gel
    • Dapsone gel
    • Tacrolimus
    • Penciclovir Cream

    2. BCS Bio-waiver Studies

    Bio-waiver studies using Caco2 cell Lines

    • Buspirone – 2 studies (Approved by USFDA – 3rd May 2018 and 16rd April 2019
    • Ramelteon (Approved by USFDA) 10th April 2020
    • Imatinib (2 studies)
    • Varenicline (3 studies)
    • Cyclophosphamide
    • Dexamphetamine
    • Levorphanol
    • Doxepin
    • Hydroxychloroquine
    • Pimavanserin
    • Brivaracetam

    3. In Vitro Binding Studies (Phase 1 & 2)

    • Colesevelam Tablets and Colesevelam Suspension
    • Sevelamer Tablet and Sevelamer Suspension
    • Sucralfate suspension

    4. In Vitro Feeding Tube Studies

    • Mycophenolate mofetil oral suspension
    • Lansoprazole delayed-release capsule
    • Dexlansoprazole delayer release capsule
    • Ticagrelor tablet